To set up a cellular system for this, we first tested ferroptosis sensitivity of a panel of KRAS-mutant lung cancer cell lines in response to erastin, which has been shown to inhibit xCT, thereby inducing ferroptosis [22]. This evidence concerns the gene KRAS and lung carcinoma.